Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of "Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate"

J Am Acad Dermatol. 2023 Jun;88(6):1385-1386. doi: 10.1016/j.jaad.2023.02.002. Epub 2023 Feb 10.

¹ Department of Dermatology, West Virginia University, Morgantown, West Virginia. Electronic address: rmtallman@hsc.wvu.edu.
² Department of Dermatology, West Virginia University, Morgantown, West Virginia.
³ Department of Dermatology, West Virginia University, Morgantown, West Virginia. Electronic address: michael.kolodney@hsc.wvu.edu.

No abstract available

Keywords: COVID-19; SARS-CoV-2; TNF-alpha; coronavirus; methotrexate; tumor necrosis factor-alpha inhibitor.

Publication types